How to get tested for bipolar disorder
Pro Research Analysisby 
Searched over 200M research papers
How to Get Tested for Bipolar Disorder
Understanding Bipolar Disorder Screening Tools
Bipolar disorder (BD) is a complex mental health condition characterized by alternating episodes of mania and depression. Accurate diagnosis is crucial for effective treatment, yet BD is often misdiagnosed or under-recognized. Several screening tools have been developed to aid in the identification of BD, including the Mood Disorder Questionnaire (MDQ), the Hypomania Checklist-32 (HCL-32), and the Bipolar Spectrum Diagnostic Scale (BSDS).
Mood Disorder Questionnaire (MDQ)
The MDQ is a widely used self-report screening tool designed to identify symptoms of bipolar spectrum disorders. It has been validated in various settings and languages, including a French version that demonstrated good sensitivity and specificity2. The MDQ typically involves a series of questions about mood symptoms and their impact on daily functioning. A score of 7 or more items is generally considered indicative of a positive screening for BD, with a sensitivity of 73% and specificity of 90% in psychiatric outpatient populations10. However, the MDQ's sensitivity can vary, being higher for bipolar I disorder compared to bipolar II disorder2.
Hypomania Checklist-32 (HCL-32)
The HCL-32 is another self-report tool specifically designed to screen for hypomanic symptoms, which are often overlooked in BD diagnosis. Studies have shown that the HCL-32 has a sensitivity of around 80% and a specificity of 57-65%, making it a reliable tool for identifying BD, particularly in distinguishing it from unipolar depression5 6. The HCL-32 has been found to be more accurate than the MDQ for detecting type II BD in mental health care settings1.
Bipolar Spectrum Diagnostic Scale (BSDS)
The BSDS is a narrative-based screening tool that captures a broader range of bipolar symptoms. It has shown good specificity (86%) and moderate sensitivity (69%) in psychiatric services1. The BSDS is particularly useful in settings where a detailed narrative can help differentiate between bipolar and other mood disorders.
Emerging Diagnostic Methods
Blood-Based Diagnostic Tests
Recent advancements have introduced blood-based diagnostic tests for BD, such as the EDIT-B test. This test measures RNA editing modifications and uses artificial intelligence to differentiate BD from unipolar depression with high accuracy (AUC of 0.935, sensitivity of 90.9%, and specificity of 84.6%)3. Such tests offer a promising alternative to traditional screening tools, providing a more objective and potentially quicker diagnosis.
Biomarker Panels
Research has also explored the use of biomarker panels for BD diagnosis. A meta-analysis identified a panel of 20 protein analytes with excellent predictive performance (AUC ≥ 0.90) for distinguishing BD from other mood disorders4. These biomarker panels could serve as valuable diagnostic tools, especially in cases where clinical symptoms alone are insufficient for a definitive diagnosis.
Practical Steps for Getting Tested
-
Self-Assessment: Begin by completing a self-report screening tool such as the MDQ or HCL-32. These questionnaires are available online and can provide an initial indication of whether you might have BD.
-
Consult a Healthcare Professional: If your self-assessment suggests the possibility of BD, schedule an appointment with a mental health professional. They can conduct a more comprehensive evaluation, including a structured clinical interview based on DSM or ICD criteria.
-
Consider Advanced Testing: In cases where traditional screening tools are inconclusive, ask your healthcare provider about advanced diagnostic options like the EDIT-B blood test or biomarker panels. These tests can offer additional insights and help confirm the diagnosis.
-
Follow-Up and Monitoring: Regular follow-up appointments are essential to monitor your symptoms and adjust your treatment plan as needed. Early and accurate diagnosis can significantly improve the management of BD and enhance your quality of life.
Conclusion
Getting tested for bipolar disorder involves a combination of self-report screening tools, professional evaluations, and potentially advanced diagnostic tests. Tools like the MDQ, HCL-32, and BSDS are effective for initial screening, while emerging methods like blood-based tests and biomarker panels offer promising new avenues for accurate diagnosis. Early detection and appropriate treatment are key to managing BD effectively and improving patient outcomes.
Sources and full results
Most relevant research papers on this topic
Screening for bipolar spectrum disorders: A comprehensive meta-analysis of accuracy studies.
The HCL-32 is more accurate than the MDQ for detecting type II bipolar disorder in mental health care settings, but more studies are needed in other settings.
Meta-Analysis
Rigorous Journal
Highly CitedScreening for bipolar disorders using a French version of the Mood Disorder Questionnaire (MDQ).
The French MDQ is a feasible and reliable screening instrument for bipolar disorders in a psychiatric outpatient sample, with comparable performance to the original American study.
Observational StudyHighly CitedClinical validation of EDIT-B test for the diagnosis of bipolar disorder
The EDIT-B test, using RNA editing modifications and AI, effectively differentiates bipolar disorder patients from unipolar depressed patients, potentially allowing for better treatment.
Rigorous JournalTowards a blood-based diagnostic panel for bipolar disorder
A blood-based diagnostic panel shows potential as an accurate and early diagnostic test for bipolar disorder, potentially preventing its onset.
Meta-AnalysisRigorous JournalThe Hypomania Checklist (HCL) - systematic review of its properties to screen for bipolar disorders.
The Hypomania Checklist (HCL-32) is a reliable screening tool for bipolar disorders, but should not be used alone for diagnosing.
Systematic ReviewComparison of the screening ability between the 32-item Hypomania Checklist (HCL-32) and the Mood Disorder Questionnaire (MDQ) for bipolar disorder: A meta-analysis and systematic review
Both the HCL-32 and MDQ are useful screening tools for bipolar disorder, with acceptable psychometric properties for identifying the disorder.
Meta-AnalysisRigorous JournalThe use of Mood Disorder Questionnaire, Hypomania Checklist-32 and clinical predictors for screening previously unrecognised bipolar disorder in a general psychiatric setting
The Hypomania Checklist-32 (HCL-32) is the best tool for detecting previously unrecognized bipolar disorder in general psychiatric settings, with bipolar family history being an increased risk factor.
Observational StudyScreening for bipolar disorder among outpatients with substance use disorders
The MDQ and HCL-32 are both sensitive but poorly specific for screening bipolar disorder in patients with substance use disorders.
Observational StudyRigorous JournalScreening for bipolar disorders: A public health issue.
Positive screening for bipolar disorder can identify sub-threshold cases with similar clinical and public health concerns, potentially improving early detection and reducing disability.
Literature ReviewDevelopment and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.
The Mood Disorder Questionnaire is a useful screening instrument for bipolar spectrum disorder in psychiatric outpatient populations, with good sensitivity and very good specificity.
Observational StudyHighly Cited